Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
12/2003
12/24/2003WO2003106401A1 N-bridged selective androgen receptor modulators and methods of use thereof
12/24/2003WO2003105854A2 Substituted dihydropyrimidines, dihydropyrimidones and dihydropyrimidinethiones as calcium channel blockers
12/24/2003WO2003091675A3 Ultrasonic doppler effect speed measurement
12/24/2003WO2003091232A3 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
12/24/2003WO2003076414A3 Aryl substituted pyrimidines and the use thereof
12/24/2003WO2003020280B1 Compositions and use thereof in the treatment of cancer
12/24/2003WO2003019697A3 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
12/24/2003CN1463263A Method to inhibit ethylene responses in plants
12/24/2003CN1462745A Miazines ramification of š�-elemene and its synthetic method
12/24/2003CN1131670C Antifungal active compound compsns.
12/24/2003CA2489182A1 N-bridged selective androgen receptor modulators and methods of use thereof
12/23/2003US6667413 Uracil compounds and use thereof
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667342 Benzenesulfonamide-derivatives and their use as medicaments
12/23/2003US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
12/18/2003WO2003104440A2 2,2-bis(hydroxymethyl)cyclopropylidenemethyl - purines and -pyrimidines as antiviral agents
12/18/2003WO2003104333A1 Yellow anionic disazo dyes
12/18/2003WO2003104206A2 Herbicidally active heterocyclylalkynes
12/18/2003WO2003104200A1 N-mercaptoacyl phenyalanine derivatives, process for their preparation, and pharmaceutical compositions containing them
12/18/2003WO2003070701B1 Syntheses of quinazolinones
12/18/2003WO2003043961A3 Modulators of rho c activity
12/18/2003WO2003031606A3 Crystal structure of an aurora kinase catalytic domain, and use thereof
12/18/2003WO2003027234A3 Small organic molecule regulators of cell proliferation
12/18/2003US20030232989 Process for the preparation of specific aromatic aldehydes
12/18/2003US20030232985 For therapy of Alzheimer's disease and Down's Syndrome
12/18/2003US20030232863 Cathepsin cysteine protease inhibitors
12/18/2003US20030232859 Antiinflammatory agents; for treatment of rheumatoid arthritis and multiple sclerosis
12/18/2003US20030232848 Pyrazole compositions
12/18/2003US20030232846 Caspase inhibitors and uses thereof
12/18/2003US20030232838 6-phenylpyrrolopyrimidinedione derivatives
12/18/2003US20030232836 Secondary amides such as 2-(4-(2- methoxyphenyl)-1-piperazinyl )-N-(3-methylphenyl)acetamide, used for prophylaxis of impotency
12/18/2003US20030232813 Novel amino substituted pyrimidinone derivatives
12/18/2003US20030232808 Sulfonyl derivatives
12/18/2003CA2488406A1 Yellow anionic disazo dyes
12/17/2003EP1371646A1 Aryl-substituted alicyclic compound and medical composition comprising the same
12/17/2003EP1371376A1 Antipruritics
12/17/2003EP1370618A1 Azo dyes containing a barbituric acid moiety, ink-jet printing inks and processes
12/17/2003EP1370540A1 Anti-thrombotic carboxylic acid amides, the production thereof and use of the same as medicaments
12/17/2003EP1370250A2 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
12/17/2003EP1206467B1 N-heterocyclic derivatives as nos inhibitors
12/17/2003EP0983225B1 New polymerisable liquid crystalline compounds
12/17/2003EP0871625B1 Preparation of triazoles by organometallic addition to ketones and intermediates therefor
12/17/2003EP0865434B1 Compounds and their use to treat infectious diseases
12/17/2003CN1462273A Bicyclic heteroaromatic compounds
12/17/2003CN1131210C Heterocyclic amide compounds and medicinal use of the same
12/16/2003US6664411 Heterocyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
12/16/2003US6664393 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
12/16/2003US6664390 Method for the simplified production of (3-chloro-4-fluorophenyl)-[7-(3-morpholin-4-yl-propoxy)-6-nitro-quinazoline-4-yl]-amine or (3-chloro-4-fluorophenyl)-[7-(3-morpholin-4-yl-propoxy)-6-amino-quinazoline-4-yl]-amine
12/16/2003US6664262 N-methoxymethyl-5,5-diphenylbarbituric acid
12/16/2003US6664214 Such as 2-(4-((2-chloro-4-fluoro-5-(3-methyl-2,6-dioxo-4-(trifluoromethyl)-1,2,3,6 -tetrahydropyrimidine-1-yl)phenoxyl)-methyl)phenoxy)propionate; herbicides
12/16/2003CA2122633C 2-heterocyclicethylamine derivatives and their use as pharmaceuticals
12/11/2003WO2003101971A1 Process for preparing (s)-tetrahydro-a-(1-methylethyl)-2-oxo-1(2h)- pyrimidineacetic acid
12/11/2003WO2003101941A2 Alpha acyloxyacetamides for kallikrein and urokinase inhibition
12/11/2003WO2003101444A1 Diarylurea compounds and derivatives as chk-1 inhibitors for the treatment of cancer
12/11/2003WO2003101442A1 Peptide deformylase inhibitors
12/11/2003WO2003101381A2 1,2 diamido cycloalkyl sodium channel blockers
12/11/2003US20030229228 Plant safening agents; fungicides
12/11/2003US20030229144 Anti-epileptogenic agents
12/11/2003US20030229132 Small molecule modulators of apoptosis
12/11/2003US20030229109 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
12/11/2003US20030229108 Angiogenesis inhibitors; antitumor agents, anticancer agents
12/11/2003US20030229103 Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides and the use thereof for selectively inhibiting collagenases
12/11/2003US20030229097 Potentiation of fungicides
12/11/2003US20030229095 Sexual disorders
12/11/2003US20030229094 Acetamides and benzamides that are useful in treating sexual dysfunction
12/11/2003US20030229093 Lipid diseases; metabolism diosrders; antiproliferative agents
12/11/2003US20030229092 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens
12/11/2003US20030229091 Heteroaromatic substituted cyclopropane as corticotropin releasing hormone ligands
12/11/2003US20030229089 Cyclic compounds
12/11/2003US20030229084 Osteoporosis; antiarthritic agents
12/11/2003US20030229081 Antiinflammatory agents, antiischemic agents, malaria, Crohn's disease, skin disorders
12/11/2003US20030229079 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
12/11/2003US20030229077 Nitrogen-containing heterocyclic compounds
12/11/2003US20030229058 Aryl aniline beta2 adrenergic receptor agonists
12/11/2003US20030229051 Anticancer agents; restenosis; atherosclerosis; skin disorders
12/11/2003US20030229050 Insecticidal anthranilamides
12/10/2003EP1369418A1 Quinazoline derivatives
12/10/2003EP1368413A1 Two-layer imageable element comprising thermally reversible polymers
12/10/2003EP1368412A1 Imageable element and composition comprising thermally reversible polymers
12/10/2003EP1368324A1 Quinazolines as mmp-13 inhibitors
12/10/2003EP1368323A1 Pyrimidine matrix metalloproteinase inhibitors
12/10/2003EP1368308A1 Cannabinoid receptor ligands
12/10/2003EP1368034A1 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
12/10/2003EP1368029A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails
12/10/2003EP1367888A2 Selective substituted aryl ketone and safener based herbicides
12/10/2003EP0933346B1 NOVEL p-TERPHENYL COMPOUNDS
12/10/2003CN1461219A Non-sedating barbiturate compounds as neuroprotective agents
12/10/2003CN1130350C Synthesis of 4,6-dichloro-2-methiopyrimidine
12/09/2003US6660872 In high yields
12/09/2003US6660751 Sulfonamide derivatives as 5-HT7 receptor antagonists
12/09/2003US6660746 Cardiovascular disorders
12/09/2003US6660740 Sorbitol dehydrogenase inhibitors
12/09/2003US6660733 Induce immunology response
12/09/2003CA2123697C Novel substituted salicylic acids
12/04/2003WO2003099818A1 Substituted quinazolinone compounds
12/04/2003WO2003099809A1 HETEROCYCLIC COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY α4 INTEGRINS
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099773A1 Ccr9 inhibitors and methods of use thereof
12/04/2003WO2003099771A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
12/04/2003WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain